Intraoperative use of tranexamic acid to reduce blood loss during cytoreductive surgery for advanced ovarian cancer: A randomized controlled clinical trial.

Acta Obstet Gynecol Scand · 2023 · PMC10333657 · PMID 37029431

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

marginally significantp = 0.051so close (0.05 < p ≤ 0.1)

The low‐dose group was marginally significant when compared with the control group ( p = 0.051).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.